Bain Capital Fund XII, LP
Insider CIK 1706270 · CERE Director, 10% owner · COHR 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COHR COHERENT CORP. | J Other | 2025-11-10 | 2025-11-12 | 254,252 | — | $0 | 0 | SEC↗ |
| COHR COHERENT CORP. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 54,023 | — | $0 | 20,977 | SEC↗ |
| COHR COHERENT CORP. | S Sale | 2025-11-07 | 2025-11-12 | 7,500,000 | $143.37 | $1.08B | 254,252 | SEC↗ |
| COHR COHERENT CORP. | C Conversion | 2025-11-07 | 2025-11-12 | 7,754,252 | — | $0 | 7,754,252 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 65,679,781 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2023-10-16 | 2023-10-18 | 5,480,052 | $22.81 | $125.00M | 65,679,781 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | J Other | 2023-06-07 | 2023-06-12 | 432,627 | — | $0 | 60,199,729 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2020-11-09 | 2020-11-12 | 332,293 | $10.30 | $3.42M | 60,632,356 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2020-10-27 | 2020-10-29 | 10,000,000 | $10.00 | $100.00M | 60,300,063 | SEC↗ |